OliX PharmaceuticalsInc (226950) — Capital Reinvestment Ratio

Latest as of September 2025: 0.19x

OliX PharmaceuticalsInc (226950) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.23 Billion) in capital expenditures (₩623.14 Million). See 226950 net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.19x

Capex / Operating Cash Flow

Operating Cash Flow

₩3.23 Billion

KRW

Capital Expenditures

₩623.14 Million

KRW

Data as of

Sep 2025

Most recent filing

Annual Capital Reinvestment Ratio for OliX PharmaceuticalsInc (None–None)

Year-by-year Capital Reinvestment Ratio for OliX PharmaceuticalsInc from None to None. For live market cap and broader valuation context, see 226950 stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow